Research Article | Open Access
Roberto Mota, Matthew J. Campen, Matthew E. Cuellar, William S. Garver, Jacob Hesterman, Mohammed Qutaish, Tamara Daniels, Monique Nysus, Carston R. Wagner, Jeffrey P. Norenberg, "111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis", Contrast Media & Molecular Imaging, vol. 2018, Article ID 6508724, 10 pages, 2018. https://doi.org/10.1155/2018/6508724
111In-DANBIRT In Vivo Molecular Imaging of Inflammatory Cells in Atherosclerosis
Atherosclerosis-related morbidity and mortality remain a global concern. Atherosclerotic disease follows a slow and silent progression, and the transition from early-stage lesions to vulnerable plaques remains difficult to diagnose. Inflammation is a key component of the development of atherosclerotic plaque and consequent life-threatening complications. This study assessed 111In-DANBIRT as an in vivo, noninvasive SPECT/CT imaging probe targeting an inflammatory marker, Lymphocyte Function Associated Antigen-1 (LFA-1), in atherosclerotic plaques. Methods. Selective binding of 111In-DANBIRT was assessed using Sprague-Dawley rats exposed to filtered air and ozone (1 ppm) by inhalation for 4 hours to induce a circulating leukocytosis and neutrophilia in peripheral blood. After 24 hours, whole blood was collected and incubated with radiolabeled DANBIRT (68Ga-DANBIRT and 111In-DANBIRT). Isolated cell component smeared slides using cytospin technique were stained with Wright-Giemsa stain. Apolipoprotein E-deficient (apoE−/−) mice were fed either a normal diet or a high-fat diet (HFD) for 8 weeks. Longitudinal SPECT/CT imaging was performed 3 hours after administration at baseline, 4, and 8 weeks of HFD diet, followed by tissue harvesting for biodistribution, serum lipid analysis, and histology. 3D autoradiography was performed in both groups 24 hours after administration of 111In-DANBIRT. Results. Increased specific uptake of radiolabeled DANBIRT by neutrophils in the ozone-exposed group was evidenced by the acute immune response due to 4-hour ozone exposure. Molecular imaging performed at 3 hours using SPECT/CT imaging evidenced an exponential longitudinal increase in 111In-DANBIRT uptake in atherosclerosis lesions in HFD-fed mice compared to normal-diet-fed mice. Such results were consistent with increased immune response to vascular injury in cardiovascular and also immune tissues, correlated by 24 hours after administration of 3D autoradiography. Histologic analysis confirmed atherosclerotic disease progression with an increased vascular lesion area in HFD-fed mice compared to normal-diet-fed mice. Conclusion. 111In-DANBIRT is a promising molecular imaging probe to assess inflammation in evolving atheroma and atherosclerotic plaque.
Atherosclerosis is a chronic cardiovascular disease common in patients exhibiting hypercholesterolemia and other inflammatory risk factors . Prevention and early diagnosis of atherosclerotic disease is a top priority in modern medicine , as early lifestyle and medical interventions can slow the rate of atheroma development, potentially averting adverse cardiovascular sequelae. Early diagnosis remains challenging because symptoms become clinically evident at later stages where prevention or reversal of lesions is no longer possible . Inflammation promotes continued vascular remodeling in late stage atheroma, making plaques unstable and vulnerable to rupture or erosion. Pathological plaque rupture is the leading cause of acute coronary syndromes, identified by thrombogenic processes and immune cell infiltration . Histological changes in vulnerable plaques such as thin fibrous cap, intraplaque hemorrhage ,and/or a lipid-rich necrotic core (LRNC) are present in ∼80% of ruptured plaques, but such pathologic features require prolonged and variable time of progression .
Cardiovascular inflammation  and remodeling due to atherogenic progression  have been identified as leading causes of plaque instability . The apoE−/− mouse model fed a high-fat diet (HFD) exhibits rapid development of atheromatous plaques , with features and stages that mirror those of human disease . Early stages of atherosclerosis typically include altered homeostasis and activation of vascular endothelium, typified by loss of nitric oxide generation and increased expression of chemokines and adhesion molecules , which is evident in the apoE−/− model . T cells and monocytes are recruited to plaques and perivascular regions, but their intraplaque specific roles have only been studied invasively postresection or postmortem imaging [13–15]. Neutrophils, part of the immediate innate response of the immunity, have been identified to have an important role in atherosclerosis development [16, 17] and plaque vulnerability . Accumulation of immune cells has been identified in the early-stage lesion of atheroma where it has been published that enzymes such as matrix metalloproteinase [19, 20] and cathepsins play a major role in the atherosclerosis inflammatory process . Experimental models of ozone exposure are used to recreate acute inflammation in animal experimental models to increase systemic inflammatory chemokines and cellularity [22–24]. DANBIRT (DOTA-butylamino-NorBIRT) (Supplemental Figure 1) was developed by chemical repurposing of BIRT 377, which is a specific therapeutic agent developed for leukemia and lymphoma, as it targets Lymphocyte Function Associated Antigen-1 (LFA-1) on both B and T cells [25–27]. DANBIRT is a small nonionic allosteric inhibitor of LFA-1 , an integrin expressed only in leukocytes , critical for initiation of a vascular immune response to injury [29, 30]. LFA-1 interacts mostly with the intracellular adhesion molecule-1 (ICAM-1) on endothelial cells to promote leukocyte arrest and transmigration . The interaction between LFA-1/ICAM-1 is mediated by chemokines, and LFA-1 affinity is highly modulated whenever LFA-1 interacts/binds to ICAM-1 [31, 32]. Our laboratory has radiolabeled DANBIRT with various radioisotopes suitable for in vivo SPECT/PET/CT imaging in small animals [33, 34].
The aim of this study is to evaluate in vivo111In-DANBIRT molecular imaging of LFA-1 expressing inflammatory leukocytes within the evolving atheroma as a marker of disease progression in the apoE-deficient mice with either a normal diet or a high-fat diet. Further, the amount of uptake of 111In-DANBIRT will characterize the degree of inflammation inside the vascular atherosclerotic plaque of apoE-deficient mice fed a HFD, known to demonstrate rapid progression of high-degree atherosclerosis.
2. Materials and Methods
2.1. Radiolabeling DANBIRT with 111In and 68Ga
DANBIRT (M.W. 886.5 G/mole) was effectively synthesized and radiolabeled using 111InCl3 and 68GaCl3 as described by Poria et al. with a specific activity of 23 Gbq/pM and a radiolabeling concentration of 1 µg:1 µL . 111Indium chloride was obtained from GE Healthcare, and 68GaCl3 was obtained as an eluate from a 67Ge/68Ga generator (Eckert and Ziegler). Radionuclide incorporation yield and radiochemical purity of radiolabeled DANBIRT were characterized by instantaneous thin layer chromatography (ITLC) and high-performance liquid chromatography (HPLC), respectively, following previously published methods .
2.2. In Vitro Stability of Radiolabeled DANBIRT
Radioligand stability of 68Ga-DANBIRT was assessed by incubating radiolabeled DANBIRT in two different solutions, Fetal Bovine Serum (FBS) and 0.9% sodium chloride (NaCl), both at 37°C. The incorporation yield (ITLC) and radiochemical purity (HPLC) were assessed at baseline, 5, 10, 30, 60, 120, and 240 minutes performed in triplicate replicates and calculated individually per sample using our previously published methods  and ultra-performance liquid chromatography (UPLC) as described in Supplemental Table 1.
2.3. Animal Studies
Whole blood was collected for in vitro and ex vivo studies from male Sprague-Dawley rats (Taconic) aged 6–8 weeks given standard food and water ad libitum. The atherosclerosis model employed male apoE−/− mice (Taconic) aged 6 weeks fed either a normal diet or a high-fat diet (HFD, Harlan-Teklad #88317) for 8 weeks; food and water were provided ad libitum. Animal experiments are summarized in Supplemental Table 2 and were performed in compliance with the Institutional Animal Care and Use Committee (IACUC).
2.4. 111In-DANBIRT Biodistribution
Mice received 26 Mbq of 111In-DANBIRT intravenously (IV) after 8 weeks of HFD or normal diet (n of 4 per group). The following organs were harvested and weighed at necropsy: whole blood, tail, aorta, liver, muscle, and adipose tissue. Whole blood was centrifuged, and serum, red blood cells (RBC), and leukocytes were collected. 111In-DANBIRT uptake was determined using a gamma counter. Uptake was decay-corrected, and percent-injected activity per gram (%IA/gr) was determined.
2.5. 68Ga-DANBIRT Biodistribution in Blood Components
As a positive control for a model of acute systemic inflammation, rats were exposed to either filtered air (FA) or ozone (1.0 ppm) for 4 hours (n of 3 per group) using a silent arc discharge ozone generator (OREC, Osmonics) to increase circulating proinflammatory cytokines, acute leukocytosis, and neutrophilia . Whole blood was collected 24 hours after exposure, and 5% hetastarch was added to whole blood prior to running isolation protocols. Histopaque neutrophil isolation protocol (10771; Sigma Aldrich) was performed; a modified protocol was used to isolate peripheral blood mononuclear cells (PBMCs) . Individual isolated samples of serum, isolated RBC, neutrophils, and PBMCs in triplicates were washed 3 times using 1x PBS and resuspended in 1% gelatin prior to 1-hour incubation with 68Ga-DANBIRT (23 Gbq/pM). After incubation, sample uptake was quantified using a gamma counter (Wallac Wizard 2; Perkin Elmer). Activity was normalized to number of cells in each sample. Cells from isolated samples were centrifuged for 15 minutes at 1000 g at 4°C for smear preparation. Slides were fixed with 5% methanol and stained using a Wright-Giemsa horizontal staining protocol (SLBN4704V; Sigma Aldrich). Cell morphology, differentials, and sample purity were assessed using a light microscope (40x objective BX51; Olympus).
2.6. 111In-DANBIRT SPECT/CT Imaging
Small-animal SPECT/CT imaging was performed 3 hours after IV injection via tail vein of 26 Mbq 111In-DANBIRT at baseline, and after 4 and 8 weeks of HFD or normal diet on a dedicated small animal imaging system (NanoSPECT/CT®; Bioscan, parameters in Supplemental Table 3) for 45-minute acquisition time under deep anesthesia using isoflurane (Piramidal Healthcare, NDC 66794-093-25). Regions of interests (ROIs) were identified using high-quality CT scan with coregistered SPECT/CT 3D reconstruction to accurately locate the tissues of interest (VivoQuant 2.00 software, Invicro) and validated by a veterinary pathologist. The ROIs were extrapolated from the reconstructed CT image and adjusted according to specific morphologic parameters for each mouse tissue such as the aortic arch, descending aorta, and muscle. Concentration and sum per volume normalized to muscle was determined to eliminate ROI signal interference from adjacent tissues. Activity was decay-corrected and compared between dietary groups (n of 4 per group).
2.7. 111In-DANBIRT 3D Autoradiography Imaging
111In-DANBIRT 3D autoradiography was performed 24 hours after IV injection via tail vein of 26 Mbq 111In-DANBIRT after 8 weeks on either normal diet or HFD. Autoradiography will enhance SPECT/CT imaging and correlate these findings by allowing functional and advanced anatomical assessment of the presence of LFA-1 expression in cardiovascular tissues. Mice were euthanized by CO2, and carcasses were individually frozen and embedded vertically in an aqueous solution of 5% carboxymethylcellulose sodium salt (CMC) in a hexane/dry ice bath. Each hexane-frozen block was stored at −20°C prior to mounting on a specimen stage in a cryomacrotome (CM3600 X; Leica). Holes were drilled in CMC blocks adjacent to the carcasses and filled with black India ink and 14C (37 kbq/mL) to provide optical and fiducial registration marks. Digital white light photographs (EOS 70D; Canon) were taken of the block surface, 50 µm thick sections in the vertical plane, from the occipital bone to the diaphragm. After every 10 slices, a section was transferred to 2.5 mm tape and dehydrated in the cryomacrotome at −20°C for 24 hours. Dehydrated sections were mounted on black cardboard with calibration standards, covered with 1.4 µm isotope imaging film (FlushTec), placed on imaging plates (Fujifilm; GE Healthcare) and exposed for 24 hours. Screens were imaged on a phosphorous imager (Typhoon FLA 7000; GE Healthcare). Autoradiography and white light files were compiled and ROIs analyzed (VivoQuant 2.00 software, inviCRO) for thymus, muscle, carotid arteries, and aortic arch, as described previously in the 3-hour 111In-DANBIRT SPECT/CT imaging methods.
2.8. Serum Lipid Levels and Subparticle Analysis
After the last imaging time point, mice were euthanized and whole blood was collected by direct cardiac puncture using heparinized syringes and centrifuged. Serum was analyzed for cholesterol, triglyceride, and size-dependent subparticle quantification (Liposearch; Skylight Biotech).
Mouse hearts were collected at necropsy, perfused, and snap frozen in liquid nitrogen. The upper third of the heart with aortic outflow tract was mounted in optimal cutting temperature (OCT) compound. 10 µm thick sections of the subaortic leaflet region were collected at −20oC (Cryostat CM 3050S; Leica). Sections were mounted on slides, incubated with Oil Red O (Sigma-Aldrich, SLBP5248V), and counterstained with Mayer’s hematoxylin (Sigma-Aldrich, SLBPG176V). Surface lesion area and arterial vessel circumference were quantified using cellSens Standard 1.13 (Olympus software) to calculate percentage of atheroma lesion area normalized to arterial wall circumference (n of 4 per group).
2.10. Immunohistochemical Analysis of Intraplaque Expression of CD11a+ (LFA-1+)
The OCT-embedded sections were fixed in methanol, washed, and incubated with fluorescein isothiocyanate conjugated (FITC) rat anti-mouse CD11a antibody 1 : 250 (SouthernBiotech) for 2 hours in a humidified chamber. Sections were counterstained with DAPI (1:1000) and imaged at 10x and 63x using a fluorescence microscope (Zeiss AxioObserver-Hamamatsu Flash4.0 sCMOS Monochrome Camera). Image processing was performed using cellSens Standard 1.13 (Olympus Software).
2.11. Statistical Methods
Data were analyzed using two-tailed Student’s t-test, one-way ANOVA, and repeated measures ANOVA. Tukey’s post hoc test and Sidak's correction test were used for multiple comparisons, and the mean differences in quantitative uptake of 3D autoradiography results were compared as %IA/gr of radiolabeled DANBIRT, normalized to muscle. Data are represented as mean ± standard error (SE) unless otherwise indicated. Resulting -values of <0.05 were considered significant (n of 4 per group). Prism 6.0 (GraphPad Software) was used for statistical analyses.
DANBIRT was efficiently radiolabeled for all experiments using both radioisotopes 111In (in vivo and ex vivo studies) and 68Ga (in vitro studies), achieving ≥95% mean incorporation yield and radiochemical purity. To illustrate radiolabeled DANBIRT in vitro stability, samples were incubated with FBS and 0.9% NaCl, and both showed >95% mean radiochemical purity and incorporation yield throughout 240 minutes (Supplemental Figures 2(a) and 2(b)).
3.1. Ex Vivo Biodistribution of 111In-DANBIRT in Atherosclerosis-Prone Mice
The biodistribution of 111In-DANBIRT ex vivo in apoE−/− mice receiving a normal diet versus a high-fat diet was evaluated. Results reflected an overall increase in all tissues of 111In-DANBIRT in HFD-fed apoE−/− mice compared to normal-diet-fed mice () (Figure 1). Numerous possible mechanisms may explain this finding, such as altered overall excretion, elevated systemic inflammation, or nonspecific sequestration of the tracer into tissues; because the finding was unexpected, the underlying mechanism was not further pursued in this study. Target tissues were normalized to muscle which showed low uptake in both groups (Figure 1(a)). The tissue with the highest uptake was the liver (Figure 1(b)), regardless of dietary supplementation, showing no significant difference between groups. Liver inspection after dissection also revealed a pale white color with fibrous consistency in all HFD-fed apoE−/− mice, absent in normal-diet-fed apoE−/− mice, suggestive of hepatic steatosis. The aorta (Figure 1(c)) reflected higher uptake in apoE−/− mice fed a HFD compared to normal diet (). 111In-DANBIRT uptake in isolated serum samples (Figure 1(d)) showed higher uptake in HFD-fed mice compared to normal diet while exhibiting higher uptake levels compared to the other blood components. Similar findings were observed in leukocytes with increased uptake in HFD-fed apoE−/− mice () (Figure 1(e)).
3.2. Neutrophil Uptake of Radiolabeled DANBIRT in Acute Systemic Inflammatory Cells
Biodistribution results showed that mice fed a HFD had increased uptake compared to normal-diet-fed mice (Figure 1). Blood obtained from rats exposed to ozone was used as a positive control to identify leukocytes in whole blood having higher uptake of 111In-DANBIRT. 68Ga-DANBIRT uptake increased in neutrophils () and unexpectedly decreased in RBC (Figure 2(a)) with no significant differences in serum or PBMC. A predominance of immature neutrophils (∼59%) (Figure 2(b)) and PBMC (∼53%) were observed in ozone-exposed rats, correlating with induced circulating leukocytosis with specific neutrophilia, without other relevant morphologic cellular changes, as previously described . This demonstrates that under acute systemic inflammatory conditions, LFA-1 affinity in neutrophils is increased and therefore a target for in vivo molecular imaging.
3.3. Characterization of Vascular Atherosclerotic Mouse Model
Histologic analysis reflected accurate development of atherosclerotic lesions in all apoE−/− mice by positive ORO tissue staining of OCT-embedded subaortic leaflets. The accumulation of inflammatory components in the subaortic leaflet region and lesion degree differed between experimental groups, especially shown in HFD-fed mice at 10x magnification (Figure 3(a)) and at a 63x magnification (Figure 3(b)). High-degree atherosclerotic lesions in HFD-fed apoE−/− mice evidenced the presence of LFA-1+ leukocytes in the vascular atherosclerotic plaque (Figure 3(c)). A scheme of the IHC images contrasted with the anatomical references (Figure 3(d)) fused from representative images is shown in Figures 3(b) and 3(c). Oil Red O-stained cryosections from normal-diet-fed apoE−/− mice showed low-degree atherosclerotic lesions (Figure 3(e)) and also compared to HFD-fed apoE−/− mice showed lower percentage of atherosclerotic lesion area in relationship to vessel wall area () (Figure 3(f)). These results confirm the enhanced disease development and inflammatory process in the vascular atherosclerotic plaque in apoE−/− mice due to the HFD.
3.4. 111In-DANBIRT Molecular Imaging of LFA-1 Expression in Atherosclerosis Development
Representative SPECT/CT 3D reconstructions show longitudinal 3-hour 111In-DANBIRT SPECT/CT scans, which allowed us to identify atherosclerosis-prone ROI established in the aortic arch and the initial portion of the descending aorta tissues shown in the representative images displayed with the ROI volumes in red color that are being pointed by the red arrows (Figure 4(a)). Representative images are shown for the analysis performed on normal-diet-fed apoE−/− mice, which evidenced the localized specific activity in the aortic arch delimited by the demarked cross pined red lines (Figure 4(b)). Representative images are also shown for the analysis performed on HFD-fed apoE−/− mice, localizing the signal in the aortic arch identified in the cross pined red lines. Analysis of ROI uptake in different experimental groups identified an increased uptake in the descending aorta (Figure 4(d)) and aorta arch (Figure 4(e)) ROI evident at 4- and 8-week time points in HFD-fed compared to normal-diet-fed apoE−/− mice by two-tailed Student’ t-test statistical analysis (Figures 4(d) and 4(e)). 24-hour 111In-DANBIRT 3D autoradiography complemented the 3-hour SPECT/CT imaging ROI determination identifying uptake of radiolabeled DANBIRT in difficult areas. Specific uptake in the common carotid arteries (Figure 5(a)), aortic arch (Figure 5(b)), and aortic outflow tract (Figure 5(c)) was identified. As a positive control, an ROI for the thymus was delimited because of its rich leukocyte presence. The two-tailed Student’s t-test showed a statistically significant increase of 111In-DANBIRT uptake in HFD-fed apoE−/− mice compared to normal-diet-fed mice specifically in the thymus (Figure 5(d)), with increased uptake in the carotid arteries, although not statistically significant.
Results of this study confirm (1) specificity of radiolabeled DANBIRT biodistribution in target tissues (Figure 1), illustrating a selective and competitive LFA-1 receptor binding in leukocytes (neutrophils) in an acute inflammatory exposure model (ozone) (Figure 2); (2) histopathologically observed development of aortic lesions (Figure 2) correlated with in vivo molecular imaging evidence of longitudinal increased uptake of 111In-DANBIRT in cardiovascular tissues in apoE−/− mice (Figures 4 and 5); and (3) accurate characterization of atherosclerosis in a mouse model identifying early-stage development of vascular atherosclerotic plaque in cardiovascular tissues (Figure 3, Supplemental Figure 3).
In vitro stability studies with 111In-DANBIRT correlated to the findings by Poria et al. and its use by Mumaw et al. substantiate its potential as a molecular imaging probe. In vitro studies demonstrated high stability of 68Ga-DANBIRT throughout 4 hours of incubation with saline to mimic physiologic conditions for radiotracer delivery (Supplemental Figure 2), eliminating the possibility of having nonspecific binding to other blood proteins that could alter the radioligand incorporation yield. 68Gallium was used for DANBIRT radiolabeling for the in vitro experiments due to its short half-life and its availability in our laboratory. Rats were used rather than mice in order to minimize the need to pool blood due to the volume needed for the Histopaque cell isolation methods. Biodistribution experiments showed that liver had a significant amount of 111In-DANBIRT in both experimental groups. This finding is anticipated because of increased blood flow and immune cells in the liver, as well as radiotracer metabolism. As an important macroscopic finding, hepatic steatosis was evidenced in HFD-fed mice. This finding will guide future studies to understand such an effect. The targeted atherosclerosis-prone cardiovascular tissues and leukocytes had increased 111In-DANBIRT uptake in mice fed a HFD. As an observation, most tissues from apoE KO mice under a HFD had higher 111In-DANBIRT retention. It has been shown that apoE KO mice develop systemic inflammation, which is substantially potentiated by a high-fat diet [35, 36], which may explain why the apoE KO mice on a HFD show general higher 111In-DANBIRT uptake. Tissue uptake of radiolabeled DANBIRT is a measure of the quantity of inflammatory cells and the location and extent of the inflammatory process. The specificity of 111In-DANBIRT was evaluated in vitro under acute inflammatory conditions, as seen in early-stage atherosclerotic disease, demonstrating increasing 111In-DANBIRT uptake in neutrophils and monocytes. Rats were exposed to ozone, a proven animal model exhibiting local and systemic acute immune response in target cells . The increased LFA-1 expression and corresponding high 111In-DANBIRT uptake in neutrophils following ozone exposure supports the concept of an acute systemic immune injury model.
The presence of 111In-DANBIRT in cardiovascular and immune tissues was evidenced by LFA-1 intraplaque expression from immunohistochemical assessment (Figure 3), while the systemic inflammatory response observed following exposure to inhaled ozone in the in vitro studies correlated to increased circulating leukocytes (Figures 2(a) and 2(b)). Macrophages are the most prevalent inflammatory cells within atherosclerotic plaques and have been hypothesized to be predictors of cardiovascular risk . Therefore, resident macrophages and immature recruited neutrophils are suitable targets for noninvasive imaging techniques . Inflammatory leukocytes have an important role of neutrophils in plaque vulnerability/instability and atherosclerosis progression via upregulation of vascular factors [18, 40, 41]. Leukocytes can be primed to increase the expression of LFA-1 and its affinity state.
The LFA-1/ICAM-1 complex is important in most vascular diseases because of its role in leukocyte recruitment and transmigration . In order for LFA-1 to bind to ICAM1, LFA-1 must be activated to a high affinity state, a process which can be imaged via radiolabeled DANBIRT . T-cell activation and migration to sites of inflammation is also guided predominantly by LFA-1/ICAM-1 interaction and Signal-2 , making the allosteric inhibition of LFA-1 an effective way to target intraplaque inflammation . Molecular imaging of LFA-1 expressing leukocytes may help understand how modulation of this integrin impacts immune progression in a variety of diseases . The results of this study show the ability of radiolabeled DANBIRT to specifically target LFA-1 to allow molecular imaging of inflammation in atherosclerosis in a mouse model.
In vivo SPECT/CT molecular imaging showed a longitudinally increased uptake in cardiovascular tissues in apoE−/− mice fed a HFD compared to normal diet (Figures 4 and 5). Tissues surrounding the vessel lamina adventitia have been identified as sites of accumulation of inflammatory cells in apoE−/− mice on normal diet . This effect was not clearly identified in these studies due to limits of spatial resolution of the SPECT imaging system. 3D autoradiography was implemented in the study to allow both functional and advanced anatomical assessment of the presence of LFA-1 expression in cardiovascular tissues. The use of 3D autoradiography in molecular imaging provides increased spatial resolution compared to in vivo SPECT/CT. This improves the accuracy of colocalization of radiolabeled DANBIRT in target tissues and subsequently the identification of volumes of tissues determined for each ROI. Because of the specificity of DANBIRT for LFA-1’s restricted expression in leukocytes and DANBIRT’s small molecular weight, 3D autoradiography was performed at 24 hours to be able to evidence the clearance of the tracer mostly from the bloodstream and major vessels after 3-hour SPECT/CT imaging. Correlation of SPECT/CT imaging 24 hours with autoradiography showed increased uptake in the resident-leukocyte-rich thymus, confirming functional and morphological distribution of 111In-DANBIRT. 3D autoradiography was critical, allowing radioligand localization in areas difficult for identification using plain CT or SPECT/CT because of the interference in the signal coming from small vessels, and the limits of detector sensitivity and specificity .
The ability of DANBIRT to assess and quantify in vivo inflammation presents an opportunity to functionally characterize developing atheroma and atherosclerosis. Current molecular imaging techniques such as FDG-PET/CT localize general metabolic activity but lack specificity for molecular events associated with inflammatory cell activation [5, 47].
Functional and morphological assessment of atherosclerotic plaque using 111In-DANBIRT relies on LFA-1’s restricted expression in leukocytes and DANBIRT’s low molecular weight and specificity. Longitudinal in vivo imaging of the inflammatory process in atherosclerotic plaque is very promising and will allow accurate and timely risk assessment of cardiovascular-related complications . 111In-DANBIRT is a promising molecular imaging probe targeting LFA-1 in the inflammatory process of vascular atherosclerotic lesions. Future investigations will be guided towards utilizing radiolabeled DANBIRT in other small animal models of vascular disease to further study its capacity and limitations. Future studies will be aimed to advance the potential of DANBIRT as a preclinical molecular imaging probe.
The source data are stored at the University of New Mexico and could be made available from the corresponding author upon request.
Conflicts of Interest
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Support provided by the KECK-UNM Small-Animal Imaging Resource (KUSAIR), the UNM Department of Anesthesiology and Critical Care Medicine, and NIH (ES014639) is gratefully acknowledged. Selita N. Lucas is gratefully acknowledged for her technical expertise and contributions to the animal studies.
Supplemental Figure 1: chemical structure of DANBIRT. DANBIRT is a chemically restructured radioligand capable of binding to LFA-1 expressed by leukocytes (M.W. 885.6 G). DOTA: 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid butylaminoNorBIRT: (R)-1-(4-aminobutyl)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-5-methylimidazolidine-2,4-dione BIRT 377: (R)-5-(4-bromobenzyl)-3-(3, 5-dichlorophenyl)-1,5-dimethylimidazolidine-2,4-dione DANBIRT: DOTA-Alkylamino-NorBIRT: [Radiometal]-DOTA-1-(4-aminobutyl)-5-(4-bromobenzyl)-3-(3,5-dichlorophenyl)-5-methylimidazolidine-2,4-dione. Supplemental Figure 2: radiolabeled DANBIRT in vitro stability. (A) Radiolabeled DANBIRT samples ran in triplicate were incubated in FBS and 0.9% saline solution, showing >95% mean radiochemical purity and incorporation yield at baseline, 5 minutes, 30 minutes, 60 minutes, 120 minutes, and 240 minutes after incubation. (B) Representative ITLC image result showing incorporation yield; peak represents ROI incorporation yield percentage >99%. Supplemental Figure 3: characterization of vascular atherosclerotic disease model. (a) Percentage of weight change from baseline compared weekly during 8 weeks of dietary assessment, showing an increase in body weight in HFD-fed mice clearly evident after 4-week time point. (b) Serum total cholesterol and (c) total triglyceride levels showed a difference between dietary groups. (d) VLDL-cholesterol was significantly higher in HFD-fed mice. (e) HDL-cholesterol did not show a difference between both groups. Concentration is represented in milligrams per deciliter (mg/dL) and in nanometers (nm) for particle size. Two-sided t-test and one-way ANOVA with multiple comparisons were used for statistical analysis (n of 4 per group). Asterisks represent statistical significance (; ; ). Supplemental Table 1: UPLC method gradient with flow rate. Supplemental Table 2: [111In] In-DANBIRT animal study design. apoE−/− mice were exposed for 8 weeks to either normal chow or high-fat chow for experiment samples. Sprague-Dawley rats were exposed to ozone or filtered air for 4 hours. Supplemental Table 3: SPECT/CT imaging parameters. (Supplementary Materials)
- Y. Arai, N. Hirose, K. Yamamura et al., “Long-Term effect of lipid-lowering therapy on atherosclerosis of abdominal aorta in patients with hypercholesterolemia: noninvasive evaluation by a new image analysis program,” Angiology, vol. 53, no. 1, pp. 57–68, 2002.
- A. T. Bykov, A. V. Chernyshev, M. A. Vartazaryan, and R. V. Lobastov, “Early diagnostics, prophylaxis, and non-pharmacological treatment of the preclinical stages of atherosclerosis and arterial hypertension,” Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kul’tury, vol. 92, no. 5, pp. 18–21, 2015.
- J. Sun, N. Balu, D. S. Hippe et al., “Subclinical carotid atherosclerosis: short-term natural history of lipid-rich necrotic core—a multicenter study with MR imaging,” Radiology, vol. 268, no. 1, pp. 61–68, 2013.
- S. Y. Choi and G. S. Mintz, “What have we learned about plaque rupture in acute coronary syndromes?” Current Cardiology Reports, vol. 12, no. 4, pp. 338–343, 2010.
- G. L. ten Kate, E. J. Sijbrands, R. Valkema et al., “Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques?” Journal of Nuclear Cardiology, vol. 17, no. 5, pp. 897–912, 2010.
- G. K. Hansson, A. K. Robertson, and C. Soderberg-Naucler, “Inflammation and atherosclerosis,” Annual Review of Pathology: Mechanisms of Disease, vol. 1, no. 1, pp. 297–329, 2006.
- K. Imanaka-Yoshida, “Tenascin-C in cardiovascular tissue remodeling,” Circulation Journal, vol. 76, no. 11, pp. 2513–2520, 2012.
- Y. Nakata and N. Maeda, “Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid,” Circulation, vol. 105, no. 12, pp. 1485–1490, 2002.
- J. Johnson, K. Carson, H. Williams et al., “Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment,” Circulation, vol. 111, no. 11, pp. 1422–1430, 2005.
- T. Sasaki, M. Kuzuya, K. Nakamura et al., “A simple method of plaque rupture induction in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. 1304–1309, 2006.
- J. Dimastromatteo, A. Broisat, P. Perret et al., “In vivo molecular imaging of atherosclerotic lesions in apoE−/− mice using VCAM-1-specific, 99mTc-labeled peptidic sequences,” Journal of Nuclear Medicine, vol. 54, no. 8, pp. 1442–1449, 2013.
- K. D. O'Brien, M. D. Allen, T. O. McDonald et al., “Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis,” Journal of Clinical Investigation, vol. 92, no. 2, pp. 945–951, 1993.
- M. M. Sadeghi, “The pathobiology of the vessel wall: implications for imaging,” Journal of Nuclear Cardiology, vol. 13, no. 3, pp. 402–414, 2006.
- W. J. M. Mulder, F. A. Jaffer, Z. A. Fayad, and M. Nahrendorf, “Imaging and nanomedicine in inflammatory atherosclerosis,” Atherosclerosis, vol. 6, no. 239, 2014.
- M. M. Sadeghi, D. K. Glover, G. M. Lanza, Z. A. Fayad, and L. L. Johnson, “Imaging atherosclerosis and vulnerable plaque,” Journal of Nuclear Medicine, vol. 51, no. 1, pp. 51S–65S, 2010.
- Y. Doring, M. Drechsler, O. Soehnlein, and C. Weber, “Neutrophils in atherosclerosis: from mice to man,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 2, pp. 288–295, 2015.
- R. Della Bona, M. T. Cardillo, M. Leo et al., “Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?” Inflammation Research, vol. 62, no. 6, pp. 537–550, 2013.
- M. van Leeuwen, M. J. Gijbels, A. Duijvestijn et al., “Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR−/− mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 84–89, 2008.
- Y. Lei, G. Yang, L. Hu et al., “Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in apoE-deficient mice under chronic stress,” International Journal of Cardiology, vol. 243, pp. 413–420, 2017.
- K. UP, R. Thomas, A. D. Ledbetter et al., “Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles,” Environmental Health Perspectives, vol. 119, no. 3, pp. 312–318, 2011.
- X. W. Cheng, G. P. Shi, M. Kuzuya, T. Sasaki, K. Okumura, and T. Murohara, “Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication,” Circulation, vol. 125, no. 12, pp. 1551–1562, 2012.
- C. R. Tyler, S. Noor, T. L. Young et al., “Aging exacerbates neuroinflammatory outcomes induced by acute ozone exposure,” Toxicological Sciences, vol. 163, no. 1, pp. 123–139, 2018.
- J. E. Mirowsky, M. S. Carraway, R. Dhingra et al., “Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients,” Environ Health, vol. 16, no. 1, p. 126, 2017.
- M. L. Paffett, K. E. Zychowski, L. Sheppard et al., “Ozone inhalation impairs coronary artery dilation via intracellular oxidative stress: evidence for serum-borne factors as drivers of systemic toxicity,” Toxicological Sciences, vol. 146, no. 2, pp. 244–253, 2015.
- E. Horst, T. Radaszkiewicz, A. Hooftman-den Otter et al., “Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade,” Leukemia, vol. 5, no. 10, pp. 848–853, 1991.
- A. Johnson, M. J. Saunders, and T. G. Back, “Stereodivergent synthesis of the LFA-1 antagonist BIRT-377 by porcine liver esterase desymmetrization and Curtius rearrangement,” Organic and Biomolecular Chemistry, vol. 13, no. 5, pp. 1463–1469, 2015.
- N. S. Chowdari and C. F. Barbas 3rd, “Total synthesis of LFA-1 antagonist BIRT-377 via organocatalytic asymmetric construction of a quaternary stereocenter,” Organic Letters, vol. 7, no. 5, pp. 867–870, 2005.
- N. K. Yee, “Self-regeneration of stereocenters: a practical enantiospecific synthesis of LFA-1 antagonist BIRT-377,” Organic Letters, vol. 2, no. 18, pp. 2781–2783, 2000.
- T. A. Kelly, “Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion,” Journal of Immunology, 2015.
- S. K. Shaw, S. Ma, M. B. Kim et al., “Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration,” Journal of Experimental Medicine, vol. 200, no. 12, pp. 1571–1580, 2004.
- M. Reina and E. Espel, “Role of LFA-1 and ICAM-1 in cancer,” Cancers, vol. 9, no. 12, p. 153, 2017.
- H. Wee, H. M. Oh, J. H. Jo, and C. D. Jun, “ICAM-1/LFA-1 interaction contributes to the induction of endothelial cell-cell separation: implication for enhanced leukocyte diapedesis,” Experimental and Molecular Medicine, vol. 41, no. 5, pp. 341–348, 2009.
- R. B. Poria, J. P. Norenberg, T. L. Anderson et al., “Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia,” Biotherapy and Radiopharmaceuticals, vol. 21, no. 5, pp. 418–426, 2006.
- C. L. Mumaw, S. Levesque, C. McGraw et al., “Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors,” FASEB Journal, vol. 30, no. 5, pp. 1880–1891, 2016.
- Y. Hirano, A. Choi, M. Tsuruta et al., “Surfactant protein-D deficiency suppresses systemic inflammation and reduces atherosclerosis in ApoE knockout mice,” Cardiovascular Research, vol. 113, no. 10, pp. 1208–1218, 2017.
- C. Lohmann, N. Schafer, T. von Lukowicz et al., “Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets,” Atherosclerosis, vol. 207, no. 2, pp. 360–367, 2009.
- Y. Ramot, U. P. Kodavanti, G. E. Kissling, A. D. Ledbetter, and A. Nyska, “Clinical and pathological manifestations of cardiovascular disease in rat models: the influence of acute ozone exposure,” Inhalation Toxicology, vol. 27, no. 1, pp. 26–38, 2015.
- A. Seneviratne, M. Hulsmans, P. Holvoet, and C. Monaco, “Biomechanical factors and macrophages in plaque stability,” Cardiovascular Research, vol. 99, no. 2, pp. 284–293, 2013.
- E. Pardali, T. Schmitz, A. Borgscheiper, J. Iking, L. Stegger, and J. Waltenberger, “Cryopreservation of primary human monocytes does not negatively affect their functionality or their ability to be labelled with radionuclides: basis for molecular imaging and cell therapy,” EJNMMI Research, vol. 6, no. 1, p. 77, 2016.
- A. K. Lund, T. L. Knuckles, C. Obot Akata et al., “Gasoline exhaust emissions induce vascular remodeling pathways involved in atherosclerosis,” Toxicological Sciences, vol. 95, no. 2, pp. 485–494, 2007.
- A. K. Lund, J. Lucero, S. Lucas et al., “Vehicular emissions induce vascular MMP-9 expression and activity associated with endothelin-1-mediated pathways,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 511–517, 2009.
- R. G. Collins, R. Velji, N. V. Guevara, M. J. Hicks, L. Chan, and A. L. Beaudet, “P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice,” Journal of Experimental Medicine, vol. 191, no. 1, pp. 189–194, 2000.
- M. E. Anderson and T. J. Siahaan, “Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors,” Peptides, vol. 24, no. 3, pp. 487–501, 2003.
- X. J. Wang, Y. Xu, L. Zhang et al., “Efficient synthesis of a small molecule, nonpeptide inhibitor of LFA-1,” Organic Letters, vol. 12, no. 19, pp. 4412–4415, 2010.
- M. P. Moos, N. John, R. Grabner et al., “The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 11, pp. 2386–2391, 2005.
- O. Ilovich, M. Qutaish, J. Hesterman et al., “Dual-isotope cryo-imaging quantitative autoradiography (CIQA): anvestigating antibody-drug conjugate distribution and payload delivery through imaging,” Journal of Nuclear Medicine, vol. 59, no. 9, pp. 1461–1466, 2018.
- L. J. Menezes, C. W. Kotze, O. Agu et al., “Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation,” Journal of Nuclear Medicine, vol. 52, no. 11, pp. 1698–1703, 2011.
- C. Burtea, S. Ballet, S. Laurent et al., “Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 6, pp. e36–e48, 2012.
Copyright © 2018 Roberto Mota et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.